𝔖 Bobbio Scriptorium

✦ LIBER ✦

Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses : N. Yamamoto, E. De Clercq, D. Schols, R. Pauwels, H. Nakashima, J. Balzarini, M. Baba, M. Hosoya, R. Snoeck, J. Neyts, G. Andrei, Z. Debyser, B.A. Murrer, B. Theobald, G. Bossard, S. Fricker, G. Henson and M. Abrams Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, Great Britain, and Johnson Matthey Pharmaceutical Research, West Chester, PA 19380, U.S.A.

Book ID: 118392808
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 64 KB
Volume: 17
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(92)90140-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative pharmacology of a group of p

Comparative pharmacology of a group of polyoxometalates possessing broad-spectrum antiviral activity : S. Fricker, B. Theobald, P. Ash, G. Bossard and E. De Clercq Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, Great Britain, Johnson Matthey Pharmaceutical Research, West Chester, PA 19380, U.S.A., and Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Potent and selective inhibition of HIV-1

Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating : E. De Clercq, N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, Z. Debyser, B.A. Murrer, D. Schwartz, D. Thornton, G. Bridger, S. Fricker, G. Henson, M. Abrams and D. Picker Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, Great Britain, and Johnson Matthey Pharmaceutical Research, West Chester, PA 19380, U.S.A.

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Synthesis and structure-activity relatio

Synthesis and structure-activity relationships in a novel class of polyamines that inhibit HIV-1 and HIV-2 replication : G. Bridger, B. Murrer, D. Schwartz, D. Thornton, S. Fricker, G. Henson, M. Abrams, D. Picker, N. Yamamoto, H. Nakashima, M. Baba, R. Pauwels and E. De Clercq Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, Great Britain, Johnson Matthey Pharmaceutical Research, West Chester, PA 19380, U.S.A., and Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 68 KB

200 In vitro activity of a novel series

200 In vitro activity of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses: S. Ikeda1, J. Neyts1, N. Yamamoto1, B. Murrer2, B. Theobald2, G. Bossard3, G. Henson3, M. Abrams3, D. Picker3 and E. De Clercq1 1Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 2Johnson Matthey, Technology Centre, Blount's Court, Sonning Common, Reading RG4 9NH, Great Britain, 3Johnson Matthey Pharmaceutical Research, 1401 King Road, West Chester, Pa 19380, U.S.A.

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

3 Highly selective and potent inhibition

3 Highly selective and potent inhibition of human immunodeficiency virus (HIV) by the novel bicyclam derivative JM31000: E. De Clercq1, N. Yamamoto1, R. Pauwels1, M. Witvrouw1, K. De Vreese1, Z. Debyser1, R. Skerlj3, D. Thornton2, G. Bridger3, G. Henson3 and M. Abrams3 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; and 3Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

32 Potent inhibition of human immunodefi

32 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Structure activity relationships: G. Bridger1, R. Skerlj1, S. Padmanabhan1, D. Thomton2, G. Henson1, M. Abrams1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 73 KB